Health
Research reveals underperformance of many Phase III oncology trials – News-Medical.Net
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than…
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in prolonging survival. The researchers…
Continue Reading
-
Noosa News20 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General12 hours agoCoalition to chart path forward as family feud cooled
-
General20 hours agoDavid Littleproud’s own goal • Inside Story
-
General9 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor